Byung Chang Jeong

Sungkyunkwan University

Papers

2

Total Citations

12

H-Index

2

About

Byung Chang Jeong is a leading urologic oncologist whose research focuses on advancing surgical outcomes for bladder cancer, particularly through robot-assisted radical cystectomy (RARC). His major contributions center on optimizing perioperative and oncologic results by comparing surgical techniques and patient-specific factors. In a landmark multi-institutional Korean study (2021, 10 citations), Jeong demonstrated that intracorporeal urinary diversion (ICUD) yields comparable oncologic outcomes to extracorporeal urinary diversion (ECUD) following RARC, providing critical evidence for minimally invasive approaches. His work also explores gender-related disparities in RARC outcomes (2022, 2 citations), revealing nuanced differences in recovery and survival between female and male patients. By leveraging large, multi-center cohorts, Jeong’s research has helped refine surgical decision-making and improve personalized care in urologic oncology. His findings are widely cited for their practical implications in robotic surgery, influencing clinical guidelines and training. Through these studies, Jeong has established himself as a key contributor to evidence-based advancements in bladder cancer treatment, bridging technical innovation with real-world patient outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
12
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Oncologic Outcomes of Intracorporeal <i>vs</i> Extracorporeal Urinary Diversion After Robot-Assisted Radical Cystectomy: A Multi-Institutional Korean Study
10 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: Sungkyunkwan University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago